VTVT logo

VTv Therapeutics (VTVT) Selling, General & Administrative Expenses

Annual SGA

$11.91 M
-$294.00 K-2.41%

December 31, 2023

Summary

Performance

1-Year Change

-2.41%

3-Year Change

+64.21%

5-Year Change

+29.1%

15-Year Change

+5.06%

VTVT SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

27.07%
VTVT annual SGA is higher than 27.07% of companies in Healthcare sector

High & Low

All-time High

$12.34 M
VTVT annual SGA is currently -3.53% below its historical high of $12.34 million

3-Year Low

$11.91 M
VTVT annual SGA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
VTVT previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 13, 2025
VTVT next annual earnings announcement is scheduled for Mar 13, 2025

OtherVTVTexpensesmetrics:

Annual Total Expenses

$25.50 M
VTVT annual total expenses is $25.50 million

Annual Operating Expenses

$25.50 M
VTVT annual total operating expenses is $25.50 million

Annual Cost Of Goods Sold

-
VTVT annual cost of goods sold value is unknown

Annual Interest Expense

$13.00 K
VTVT annual interest expense is $13.00 thousand

Quarterly SGA

$3.28 M
-$434.00 K-11.68%

September 30, 2024

Summary

Performance

3-Month Change

-11.68%

1-Year Change

-11.68%

3-Year Change

-0.82%

5-Year Change

+93.63%

VTVT Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

28.43%
VTVT quarterly SGA is higher than 28.43% of companies in Healthcare sector

High & Low

All-time High

$5.72 M
VTVT quarterly SGA is currently -42.58% below its historical high of $5.72 million

3-Year Low

$1.83 M
VTVT quarterly SGA is currently +79.25% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VTVT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
VTVT next earnings announcement is scheduled for Mar 13, 2025

OtherVTVTexpensesmetrics:

Quarterly Total Expenses

$6.51 M
VTVT quarterly total expenses is $6.51 million

Quarterly Operating Expenses

$6.51 M
VTVT quarterly total operating expenses is $6.51 million

Quarterly Cost Of Goods Sold

-
VTVT quarterly cost of goods sold value is unknown

Quarterly Interest Expense

$0.00
VTVT quarterly interest expense is $0.00

TTM SGA

-$1.15 B
-$14.89 M-1.31%

September 30, 2024

Summary

Performance

3-Month Change

-9114.98%

1-Year Change

-9114.98%

3-Year Change

-9871.06%

5-Year Change

-14707.14%

VTVT TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

41.08%
VTVT TTM SGA is higher than 41.08% of companies in Healthcare sector

High & Low

All-time High

-$498.81 M

3-Year Low

-$1.15 B
VTVT TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VTVT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
VTVT next earnings announcement is scheduled for Mar 13, 2025

OtherVTVTexpensesmetrics:

Annual Total Expenses

$25.50 M
VTVT annual total expenses is $25.50 million

Annual Operating Expenses

$25.50 M
VTVT annual total operating expenses is $25.50 million

TTM Cost Of Goods Sold

-
VTVT TTM cost of goods sold value is unknown

TTM Interest Expense

$7000.00
VTVT TTM interest expense is $7000.00

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$11.91 M
VTVT annual SGA is $11.91 million

Annual Operating Expenses

$25.50 M
VTVT annual total operating expenses is $25.50 million

Annual Cost Of Goods Sold

-
VTVT annual cost of goods sold value is unknown

VTVT Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-2.4%-11.7%-9115.0%
3 y3 years+64.2%-0.8%-9871.1%
5 y5 years+29.1%+93.6%-10000.0%

VTVT Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-3.5%at low-42.6%+79.3%-14.4%at low
5 y5-year-3.5%+64.2%-42.6%+206.4%-29.0%at low
alltimeall time-3.5%+64.2%-42.6%+206.4%-131.5%+38.1%

VTv Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$3.28 M(-11.7%)
$13.54 M(+5.8%)
Jun 2024
-
$3.72 M(-6.6%)
$12.81 M(+3.3%)
Mar 2024
-
$3.98 M(+54.8%)
$12.40 M(+4.1%)
Dec 2023
$11.91 M(-2.4%)
$2.57 M(+1.0%)
$11.91 M(+1.5%)
Sep 2023
-
$2.54 M(-23.1%)
$11.73 M(-0.8%)
Jun 2023
-
$3.31 M(-5.1%)
$11.82 M(+14.3%)
Mar 2023
-
$3.48 M(+45.9%)
$10.34 M(-15.3%)
Dec 2022
$12.20 M(-1.2%)
$2.39 M(-9.3%)
$12.20 M(-21.4%)
Sep 2022
-
$2.63 M(+43.9%)
$15.53 M(+2.7%)
Jun 2022
-
$1.83 M(-65.8%)
$15.12 M(-2.6%)
Mar 2022
-
$5.35 M(-6.4%)
$15.53 M(+25.8%)
Dec 2021
$12.34 M(+70.2%)
$5.72 M(+157.4%)
$12.34 M(+42.5%)
Sep 2021
-
$2.22 M(-0.9%)
$8.66 M(+15.3%)
Jun 2021
-
$2.24 M(+3.6%)
$7.51 M(+7.9%)
Mar 2021
-
$2.16 M(+6.3%)
$6.96 M(-3.9%)
Dec 2020
$7.25 M(-15.1%)
$2.04 M(+90.0%)
$7.25 M(+0.6%)
Sep 2020
-
$1.07 M(-36.8%)
$7.21 M(-8.8%)
Jun 2020
-
$1.70 M(-30.8%)
$7.90 M(-8.1%)
Mar 2020
-
$2.45 M(+23.2%)
$8.60 M(+0.7%)
Dec 2019
$8.54 M
$1.99 M(+12.4%)
$8.54 M(-1.0%)
Sep 2019
-
$1.77 M(-26.0%)
$8.62 M(-4.3%)
Jun 2019
-
$2.39 M(+0.3%)
$9.01 M(-3.7%)
DateAnnualQuarterlyTTM
Mar 2019
-
$2.39 M(+15.1%)
$9.35 M(+1.4%)
Dec 2018
$9.22 M(-18.6%)
$2.07 M(-3.9%)
$9.22 M(-8.6%)
Sep 2018
-
$2.16 M(-21.2%)
$10.09 M(-3.9%)
Jun 2018
-
$2.74 M(+21.4%)
$10.50 M(-2.5%)
Mar 2018
-
$2.25 M(-23.2%)
$10.76 M(-5.0%)
Dec 2017
$11.33 M(+14.4%)
$2.94 M(+14.4%)
$11.33 M(+6.4%)
Sep 2017
-
$2.57 M(-14.6%)
$10.65 M(+1.6%)
Jun 2017
-
$3.00 M(+6.4%)
$10.48 M(+3.3%)
Mar 2017
-
$2.82 M(+25.4%)
$10.15 M(+2.5%)
Dec 2016
$9.91 M(+9.1%)
$2.25 M(-6.2%)
$9.91 M(-1.2%)
Sep 2016
-
$2.40 M(-10.1%)
$10.02 M(-0.1%)
Jun 2016
-
$2.67 M(+3.5%)
$10.04 M(+3.9%)
Mar 2016
-
$2.58 M(+8.9%)
$9.66 M(+6.5%)
Dec 2015
$9.08 M(-22.5%)
$2.37 M(-1.9%)
$9.08 M(+2.6%)
Sep 2015
-
$2.42 M(+5.1%)
$8.85 M(+10.3%)
Jun 2015
-
$2.30 M(+15.1%)
$8.02 M(-6.5%)
Mar 2015
-
$2.00 M(-6.8%)
$8.59 M(-26.7%)
Dec 2014
$11.72 M(+3.0%)
$2.14 M(+34.4%)
$11.72 M(+22.3%)
Sep 2014
-
$1.59 M(-44.3%)
$9.58 M(+19.9%)
Jun 2014
-
$2.86 M(-44.3%)
$7.99 M(+55.7%)
Mar 2014
-
$5.13 M
$5.13 M
Dec 2013
$11.38 M
-
-

FAQ

  • What is vTv Therapeutics annual SGA?
  • What is the all time high annual SGA for vTv Therapeutics?
  • What is vTv Therapeutics annual SGA year-on-year change?
  • What is vTv Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for vTv Therapeutics?
  • What is vTv Therapeutics quarterly SGA year-on-year change?
  • What is vTv Therapeutics TTM SGA?
  • What is the all time high TTM SGA for vTv Therapeutics?
  • What is vTv Therapeutics TTM SGA year-on-year change?

What is vTv Therapeutics annual SGA?

The current annual SGA of VTVT is $11.91 M

What is the all time high annual SGA for vTv Therapeutics?

vTv Therapeutics all-time high annual SGA is $12.34 M

What is vTv Therapeutics annual SGA year-on-year change?

Over the past year, VTVT annual SGA has changed by -$294.00 K (-2.41%)

What is vTv Therapeutics quarterly SGA?

The current quarterly SGA of VTVT is $3.28 M

What is the all time high quarterly SGA for vTv Therapeutics?

vTv Therapeutics all-time high quarterly SGA is $5.72 M

What is vTv Therapeutics quarterly SGA year-on-year change?

Over the past year, VTVT quarterly SGA has changed by -$434.00 K (-11.68%)

What is vTv Therapeutics TTM SGA?

The current TTM SGA of VTVT is -$1.15 B

What is the all time high TTM SGA for vTv Therapeutics?

vTv Therapeutics all-time high TTM SGA is -$498.81 M

What is vTv Therapeutics TTM SGA year-on-year change?

Over the past year, VTVT TTM SGA has changed by -$1.17 B (-9114.98%)